DK2081955T3 - Metastinderivater og anvendelse deraf - Google Patents

Metastinderivater og anvendelse deraf Download PDF

Info

Publication number: DK2081955T3
Authority: DK; Denmark
Prior art keywords: metastin derivatives; metastin; derivatives
Prior art date: 2006-10-25

Application number

DK07830903.6T

Other languages

English (en)

Inventor

Taiji Asami

Naoki Nishizawa

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-25

Filing date

2007-10-24

Publication date

2015-06-15

2007-10-24 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2015-06-15 Application granted granted Critical

2015-06-15 Publication of DK2081955T3 publication Critical patent/DK2081955T3/da

Links

KAHDONZOCXSKII-NJVVDGNHSA-N kisspeptin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C1=CN=CN1 KAHDONZOCXSKII-NJVVDGNHSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Zoology (AREA)
Physical Education & Sports Medicine (AREA)
Biochemistry (AREA)
Gynecology & Obstetrics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Pregnancy & Childbirth (AREA)
Oncology (AREA)

DK07830903.6T 2006-10-25 2007-10-24 Metastinderivater og anvendelse deraf DK2081955T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2006290536		2006-10-25
JP2007021387		2007-01-31
JP2007221911		2007-08-28
PCT/JP2007/071169 WO2008050897A1 (en)	2006-10-25	2007-10-24	Metastin derivatives and use thereof

Publications (1)

Publication Number	Publication Date
DK2081955T3 true DK2081955T3 (da)	2015-06-15

Family

ID=38925530

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07830903.6T DK2081955T3 (da)	2006-10-25	2007-10-24	Metastinderivater og anvendelse deraf

Country Status (34)

Country	Link
US (2)	US7786083B2 (da)
EP (1)	EP2081955B1 (da)
JP (2)	JP2010507565A (da)
KR (1)	KR101424306B1 (da)
AR (1)	AR063367A1 (da)
AU (1)	AU2007309969B2 (da)
BR (1)	BRPI0717441B8 (da)
CA (1)	CA2667537C (da)
CL (1)	CL2007003053A1 (da)
CR (1)	CR10799A (da)
CY (1)	CY1116627T1 (da)
DK (1)	DK2081955T3 (da)
EC (1)	ECSP099279A (da)
ES (1)	ES2539430T3 (da)
GE (1)	GEP20125568B (da)
HK (1)	HK1130500A1 (da)
HR (1)	HRP20150819T1 (da)
HU (1)	HUE025291T2 (da)
IL (1)	IL198046A (da)
JO (1)	JO3048B1 (da)
MA (1)	MA30887B1 (da)
ME (1)	ME00786B (da)
MX (1)	MX2009004148A (da)
MY (1)	MY145975A (da)
NO (1)	NO341584B1 (da)
NZ (1)	NZ576375A (da)
PE (1)	PE20081469A1 (da)
PL (1)	PL2081955T3 (da)
PT (1)	PT2081955E (da)
RS (1)	RS54083B1 (da)
SI (1)	SI2081955T1 (da)
TN (1)	TN2009000140A1 (da)
TW (1)	TWI404726B (da)
WO (1)	WO2008050897A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20050090420A (ko)	2002-12-26	2005-09-13	다케다 야쿠힌 고교 가부시키가이샤	메타스틴 유도체 및 이의 용도
AU2005257484A1 (en) *	2004-06-25	2006-01-05	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
TWI386417B (zh)	2005-12-22	2013-02-21	Takeda Pharmaceutical	轉移抑素衍生物及其用途
US20090099334A1 (en) *	2005-12-22	2009-04-16	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
US8404643B2 (en) *	2005-12-22	2013-03-26	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
US20090093615A1 (en) *	2005-12-22	2009-04-09	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
JP5279021B2 (ja) *	2006-04-26	2013-09-04	国立大学法人京都大学	Ｇｐｒ５４アゴニスト活性を有する新規化合物
JO3048B1 (ar)	2006-10-25	2016-09-05	Takeda Pharmaceuticals Co	مشتقات متاستين واستخدامها
US8110639B2 (en) *	2006-11-17	2012-02-07	Solvay Advanced Polymers, L.L.C.	Transparent and flame retardant polysulfone compositions
WO2009131191A1 (ja) *	2008-04-24	2009-10-29	武田薬品工業株式会社	メタスチン誘導体およびその用途
JP5700641B2 (ja) *	2008-04-30	2015-04-15	国立大学法人京都大学	メタスチン誘導体およびその用途
US20110212890A1 (en) *	2008-07-30	2011-09-01	Takeda Pharmaceutical Company Limited	Metastin derivative and use thereof
WO2010137022A1 (en) *	2009-05-27	2010-12-02	Yeda Research And Development Co. Ltd	Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
SG186070A1 (en) *	2010-06-25	2013-01-30	Takeda Pharmaceutical	Sustained-release formulation
WO2013017631A1 (en)	2011-08-04	2013-02-07	Msd Oss B.V.	Kisspeptide-pentasaccharide conjugates
WO2014198372A1 (de) *	2013-06-12	2014-12-18	Merck Patent Gmbh	Hydroxyethylenderivate zur behandlung von arthrose
US10220069B2 (en) *	2014-01-22	2019-03-05	The Johns Hopkins University	Compositions and methods for treating diabetes
JP6253146B2 (ja) *	2014-02-04	2017-12-27	国立大学法人山口大学	新規なペプチド誘導体及びこれを含有する医薬
CN107428803A (zh) *	2015-02-08	2017-12-01	耶路撒冷希伯来大学伊萨姆研究发展有限公司	用于治疗恶性增殖性疾病的肽
EP3650464A4 (en) *	2017-07-05	2021-01-13	XDCExplorer (Shanghai) Co., Ltd.	PEPTIDIC COMPOUND AND ITS APPLICATION, AND COMPOSITION CONTAINING A PEPTIDIC COMPOUND
TWI795462B (zh) *	2017-11-17	2023-03-11	日商鹽野義製藥股份有限公司	光安定性及溶出性優異的醫藥製劑

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL74827A (en)	1984-05-21	1989-06-30	Salk Inst For Biological Studi	Peptides active as gnrh antagonists and pharmaceutical compositions containing them
MX9100717A (es)	1990-08-24	1992-04-01	Syntex Inc	Antagonistas de la bradiquinina
US5824784A (en)	1994-10-12	1998-10-20	Amgen Inc.	N-terminally chemically modified protein compositions and methods
AU7333496A (en)	1995-10-19	1997-05-07	Takeda Chemical Industries Ltd.	Quinoline derivatives as gnrh antagonists
JPH09169735A (ja)	1995-10-19	1997-06-30	Takeda Chem Ind Ltd	キノリン誘導体、その製造法および用途
JP2000510453A (ja)	1996-04-19	2000-08-15	ノボノルディスクアクティーゼルスカブ	成長ホルモン遊離特性を有する化合物
CA2283299A1 (en)	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	186 human secreted proteins
JP4486187B2 (ja)	1998-10-27	2010-06-23	武田薬品工業株式会社	新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド
US6528054B1 (en)	1998-12-28	2003-03-04	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
JP3822822B2 (ja)	1999-06-28	2006-09-20	ビーエーエスエフアクチェンゲゼルシャフト	腫瘍の成長を予防する方法
US6638906B1 (en)	1999-12-13	2003-10-28	Nobex Corporation	Amphiphilic polymers and polypeptide conjugates comprising same
KR20020065510A (ko)	1999-12-17	2002-08-13	다케다 야쿠힌 고교 가부시키가이샤	ＫｉＳＳ-1 펩티드의 제조 방법
PL366626A1 (en)	2000-03-29	2005-02-07	Corixa Corporation	Compositions and methods for the therapy and diagnosis of lung cancer
WO2001075104A1 (fr)	2000-03-30	2001-10-11	Takeda Chemical Industries, Ltd.	Nouvelle proteine, adn codant pour celle-ci, et son procede de production
US7834141B1 (en)	2000-03-31	2010-11-16	Theresa Siler-Khodr	Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy
RU2311920C2 (ru)	2000-09-20	2007-12-10	Корикса Корпорейшн	Композиции и способы для лечения и диагностики рака легких
JP2003026601A (ja)	2000-11-29	2003-01-29	Takeda Chem Ind Ltd	医薬組成物およびその製造法
JP2002320496A (ja)	2001-02-26	2002-11-05	Takeda Chem Ind Ltd	新規マウス型ＫｉＳＳ−１レセプタータンパク質およびそのＤＮＡ
WO2002085399A1 (en)	2001-04-20	2002-10-31	Takeda Chemical Industries, Ltd.	Peptide-containing preparations
US20040185525A1 (en) *	2001-05-17	2004-09-23	Osamu Nishimura	Process for producing peptide
DE60219645T2 (de)	2001-09-19	2007-08-09	Takeda Pharmaceutical Co. Ltd.	Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
AU2003201854A1 (en)	2002-01-11	2003-07-30	Takeda Chemical Industries, Ltd.	PROCESS FOR PRODUCING KiSS-1 PEPTIDE
JP2003300906A (ja)	2002-04-12	2003-10-21	Daiichi Fine Chemical Co Ltd	がん転移抑制因子の安定化
CA2501556A1 (en) *	2002-10-09	2004-04-29	Kyowa Hakko Kogyo Co., Ltd.	Remedy for hormone-dependent cancer
WO2004038021A1 (en)	2002-10-25	2004-05-06	Paradigm Therapeutics Limited	Gpr54 knock-out mammals and screening methods using them
JP4804714B2 (ja)	2002-12-26	2011-11-02	武田薬品工業株式会社	メタスチン誘導体およびその用途
KR20050090420A (ko)	2002-12-26	2005-09-13	다케다 야쿠힌 고교 가부시키가이샤	메타스틴 유도체 및 이의 용도
US6800611B2 (en) *	2003-01-06	2004-10-05	Takeda Chemical Industries, Ltd.	Metastin derivatives and their use
KR100595364B1 (ko)	2003-02-20	2006-07-03	재단법인 목암생명공학연구소	Ｌｋ8 단백질을 유효성분으로 포함하는 항암제
EP1604682A4 (en)	2003-03-12	2009-06-24	Takeda Chemical Industries Ltd	AGENTS IMPROVING GONADIC FUNCTION
EP1464652A1 (en)	2003-04-02	2004-10-06	Institut National De La Sante Et De La Recherche Medicale (Inserm)	GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases
US20050002935A1 (en)	2003-04-17	2005-01-06	Vincent Ling	Use of B7-H3 as an immunoregulatory agent
CA2523600A1 (en)	2003-04-28	2004-11-11	Wyeth	Methods utilising g-protein coupled receptor 54
WO2004101747A2 (en)	2003-05-07	2004-11-25	The General Hospital Corporation	Identification and use of gpr54 and its ligands for reproductive disorders and contraception
WO2004106289A1 (en)	2003-05-30	2004-12-09	Prozymex A/S	Protease inhibitors
WO2005042744A1 (fr)	2003-11-03	2005-05-12	Beijing Sunbio Biotech Co., Ltd.	Proteine de recombinaison anticancereuse, ses genes codant et ses utilisations
WO2005095973A2 (en)	2004-03-25	2005-10-13	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54)
WO2005117939A2 (en)	2004-04-23	2005-12-15	Applied Research Systems Ars Holding N.V.	Use of gpcr54 ligands for the treatment of infertility
AU2005257484A1 (en) *	2004-06-25	2006-01-05	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
WO2007084211A2 (en)	2005-11-11	2007-07-26	The General Hospital Corporation	Use of gpr54 ligands for treatment of reproductive disorders, proliferative disorders, and for contraception
US8404643B2 (en)	2005-12-22	2013-03-26	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
US20090093615A1 (en) *	2005-12-22	2009-04-09	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
TWI386417B (zh) *	2005-12-22	2013-02-21	Takeda Pharmaceutical	轉移抑素衍生物及其用途
US20090099334A1 (en) *	2005-12-22	2009-04-16	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
EP1999143B1 (en)	2006-03-20	2011-07-13	Merck Sharp & Dohme Corp.	Neuromedin u receptor agonists and uses thereof
WO2007109857A1 (en) *	2006-03-28	2007-10-04	Biopharmica Ltd	Agent for the treatment of hormone-dependent disorders and uses thereof
JO3048B1 (ar)	2006-10-25	2016-09-05	Takeda Pharmaceuticals Co	مشتقات متاستين واستخدامها
EP2206721A1 (en)	2007-10-05	2010-07-14	Takeda Pharmaceutical Company Limited	Neuromedin u derivative
WO2009131191A1 (ja)	2008-04-24	2009-10-29	武田薬品工業株式会社	メタスチン誘導体およびその用途
EP2340047A1 (en)	2008-09-19	2011-07-06	Nektar Therapeutics	Polymer conjugates of kiss1 peptides

2007
- 2007-10-23 JO JOP/2007/0448A patent/JO3048B1/ar active
- 2007-10-23 TW TW096139608A patent/TWI404726B/zh active
- 2007-10-24 BR BRPI0717441A patent/BRPI0717441B8/pt active IP Right Grant
- 2007-10-24 AU AU2007309969A patent/AU2007309969B2/en active Active
- 2007-10-24 GE GEAP200711265A patent/GEP20125568B/en unknown
- 2007-10-24 ME MEP-2009-130A patent/ME00786B/me unknown
- 2007-10-24 US US11/977,477 patent/US7786083B2/en active Active
- 2007-10-24 SI SI200731649T patent/SI2081955T1/sl unknown
- 2007-10-24 HU HUE07830903A patent/HUE025291T2/en unknown
- 2007-10-24 EP EP20070830903 patent/EP2081955B1/en active Active
- 2007-10-24 NZ NZ576375A patent/NZ576375A/en unknown
- 2007-10-24 MY MYPI20091689A patent/MY145975A/en unknown
- 2007-10-24 CL CL200703053A patent/CL2007003053A1/es unknown
- 2007-10-24 PT PT78309036T patent/PT2081955E/pt unknown
- 2007-10-24 DK DK07830903.6T patent/DK2081955T3/da active
- 2007-10-24 ES ES07830903.6T patent/ES2539430T3/es active Active
- 2007-10-24 MX MX2009004148A patent/MX2009004148A/es active IP Right Grant
- 2007-10-24 PL PL07830903T patent/PL2081955T3/pl unknown
- 2007-10-24 RS RS20150413A patent/RS54083B1/en unknown
- 2007-10-24 AR ARP070104699A patent/AR063367A1/es active IP Right Grant
- 2007-10-24 CA CA2667537A patent/CA2667537C/en active Active
- 2007-10-24 US US12/446,142 patent/US8765909B2/en active Active
- 2007-10-24 PE PE2007001444A patent/PE20081469A1/es active IP Right Grant
- 2007-10-24 WO PCT/JP2007/071169 patent/WO2008050897A1/en active Application Filing
- 2007-10-24 JP JP2009518179A patent/JP2010507565A/ja active Pending
- 2007-10-24 KR KR1020097010545A patent/KR101424306B1/ko active Active
2009
- 2009-04-06 IL IL198046A patent/IL198046A/en active IP Right Grant
- 2009-04-15 TN TNP2009000140A patent/TN2009000140A1/fr unknown
- 2009-04-16 NO NO20091487A patent/NO341584B1/no unknown
- 2009-04-23 EC EC2009009279A patent/ECSP099279A/es unknown
- 2009-05-13 MA MA31868A patent/MA30887B1/fr unknown
- 2009-05-15 CR CR10799A patent/CR10799A/es unknown
- 2009-09-21 HK HK09108616.8A patent/HK1130500A1/xx unknown
2013
- 2013-01-11 JP JP2013004011A patent/JP5686825B2/ja active Active
2015
- 2015-07-28 HR HRP20150819TT patent/HRP20150819T1/hr unknown
- 2015-07-29 CY CY20151100668T patent/CY1116627T1/el unknown

Also Published As

Publication number	Publication date
KR20090090315A (ko)	2009-08-25
CL2007003053A1 (es)	2008-08-08
CA2667537A1 (en)	2008-05-02
AU2007309969A2 (en)	2009-06-04
IL198046A0 (en)	2011-08-01
EP2081955B1 (en)	2015-05-06
AR063367A1 (es)	2009-01-21
US7786083B2 (en)	2010-08-31
NO20091487L (no)	2009-07-07
TWI404726B (zh)	2013-08-11
ME00786B (me)	2011-12-20
MX2009004148A (es)	2009-05-01
AU2007309969B2 (en)	2012-04-19
TW200823232A (en)	2008-06-01
MY145975A (en)	2012-05-31
PT2081955E (pt)	2015-07-10
WO2008050897A1 (en)	2008-05-02
US8765909B2 (en)	2014-07-01
BRPI0717441B8 (pt)	2021-05-25
PL2081955T3 (pl)	2015-10-30
TN2009000140A1 (en)	2010-10-18
ECSP099279A (es)	2009-06-30
IL198046A (en)	2014-06-30
CY1116627T1 (el)	2017-03-15
MA30887B1 (fr)	2009-11-02
HRP20150819T1 (hr)	2015-09-11
HK1130500A1 (en)	2009-12-31
GEP20125568B (en)	2012-07-10
ES2539430T3 (es)	2015-06-30
JP2010507565A (ja)	2010-03-11
JP2013075913A (ja)	2013-04-25
US20090215700A1 (en)	2009-08-27
AU2007309969A1 (en)	2008-05-02
PE20081469A1 (es)	2008-12-25
CA2667537C (en)	2017-01-17
NZ576375A (en)	2011-07-29
NO341584B1 (no)	2017-12-11
SI2081955T1 (sl)	2015-06-30
HUE025291T2 (en)	2016-02-29
KR101424306B1 (ko)	2014-08-01
EP2081955A1 (en)	2009-07-29
JO3048B1 (ar)	2016-09-05
US20110059888A1 (en)	2011-03-10
RS54083B1 (en)	2015-10-30
BRPI0717441A2 (pt)	2013-11-19
BRPI0717441B1 (pt)	2019-07-02
JP5686825B2 (ja)	2015-03-18
CR10799A (es)	2009-06-09

Publication	Publication Date	Title
DK2081955T3 (da)	2015-06-15	Metastinderivater og anvendelse deraf
DK1963362T3 (da)	2011-09-19	Metastinderivater og anvendelse deraf
DK2170827T3 (da)	2013-11-18	Indolin-2-oner og aza-indolin-2-oner
DK2001556T3 (da)	2014-11-10	Thioninium-forbindelser og anvendelse deraf
DK2118140T3 (da)	2013-07-01	Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
DK2185552T3 (da)	2014-06-10	Dipeptoid-prodrugs og anvendelse heraf
DK1894567T3 (da)	2012-11-19	Ledsagende farmaceutiske midler og anvendelse deraf
DE602007010795D1 (de)	2011-01-05	Blattsauger und -häcksler
DE602007010981D1 (de)	2011-01-13	Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate
DK1954140T3 (da)	2013-06-17	Glycerollevulinatketaler og deres anvendelse
DK2079485T3 (da)	2012-08-06	Phenylpropionamidforbindelser og anvendelsen deraf
DK3586901T3 (da)	2022-04-25	Kateteriseringsindretning og kit
DK2016080T3 (da)	2010-11-22	Dihydropyrazolopyrimidinon-derivater
ATE483711T1 (de)	2010-10-15	Spiroindolinonderivate
ATE469905T1 (de)	2010-06-15	Pyridopyrimidinonderivate
ATE512135T1 (de)	2011-06-15	Spiroindolinonderivate
DK1885716T3 (da)	2013-02-11	Thiazolderivater og anvendelse deraf
DK3338790T3 (da)	2022-05-09	Oligopeptid-forbindelser og anvendelser deraf
DK2035394T3 (da)	2009-10-05	2-pyrazincarboxamidderivater
DK2160336T3 (da)	2013-07-22	Forbindelsesmekanisme og fremgangsmåde
DK2096167T3 (da)	2013-02-04	Aptamer mod midkin og anvendelse deraf
DK1863801T3 (da)	2010-11-15	Benzimidazolderivat og anvendelse deraf
DK2086968T3 (da)	2012-03-19	5-hydroxymethyl-oxazolidin-2-on-derivater
BRPI0817844A2 (pt)	2015-04-07	Derivados de 3-alcóxi-1-fenilpirazol e pesticidas
DK1999403T3 (da)	2014-06-16	Multikoblingssystem og fremgangsmåde relateret dertil